価格表
在庫・価格 : 2025年06月08日 05時19分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Osteoprotegerin/Fc Chimera, Mouse, Recombinant, Carrier-free データシート |
459-MO-100 |
RSDアールアンドディー システムズ R&D Systems, Inc. |
100 μg | ¥90,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年06月08日 05時19分 現在
使用文献
- No.: 1
-
文献情報:
Toraldo G et al. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. Proc. Natl. Acad. Sci. U.S.A. 2003 Jan;100(1):125-30
Toraldo G et al
2003/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 2
-
文献情報:
Cao J et al. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. J. Bone Miner. Res. 2003 Feb;18(2):270-7
Cao J et al
2003/01/01
-
備考:
Application: Western Blot -
参照:
- No.: 3
-
文献情報:
Karst M et al. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J. Cell. Physiol. 2004 Jul;200(1):99-106
Karst M et al
2004/01/01
-
備考:
Species: Mouse, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 4
-
文献情報:
Bengtsson AK et al. 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. Blood 2004 Sep;104(5):1404-10
Bengtsson AK et al
2004/01/01
-
備考:
Application: ELISA Standard -
参照:
- No.: 5
-
文献情報:
Ishizuka K et al. Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neurosci. Lett. 2005 Apr;379(1):47-51
Ishizuka K et al
2005/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 6
-
文献情報:
Gustafsson BI et al. Serotonin and fluoxetine modulate bone cell function in vitro. J. Cell. Biochem. 2006 May;98(1):139-51
Gustafsson BI et al
2006/01/01
-
備考:
Application: ELISA Standard -
参照:
- No.: 7
-
文献情報:
Berry JE et al. JunB as a downstream mediator of PTHrP actions in cementoblasts. J. Bone Miner. Res. 2006 Feb;21(2):246-57
Berry JE et al
2006/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 8
-
文献情報:
Nakamichi Y et al. Osteoprotegerin reduces the serum level of receptor activator of NF-kappaB ligand derived from osteoblasts. J. Immunol. 2007 Jan;178(1):192-200
Nakamichi Y et al
2007/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 9
-
文献情報:
Schrader J et al. Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death. Diabetologia 2007 Jun;50(6):1243-7
Schrader J et al
2007/01/01
-
備考:
Species: Rat, Application: Bioassay, Sample type: Whole Cells -
参照:
- No.: 10
-
文献情報:
Onal M et al. Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss. J. Biol. Chem. 2012 Aug;287(35):29851-60
Onal M et al
2012/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 11
-
文献情報:
Charles JF et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J. Clin. Invest. 2012 Dec;122(12):4592-605
Charles JF et al
2012/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 12
-
文献情報:
Rementer CW et al. An inducible, ligand-independent receptor activator of NF-κB gene to control osteoclast differentiation from monocytic precursors. PLoS ONE 2013;8(12):e84465
Rementer CW et al
2013/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 13
-
文献情報:
Takeshita S et al. Age-related marrow adipogenesis is linked to increased expression of RANKL. J. Biol. Chem. 2014 Jun;289(24):16699-710
Takeshita S et al
2014/01/01
-
備考:
Application: Bioassay, Sample Type: Whole Cells -
参照:
- No.: 14
-
文献情報:
Mukai T et al. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss. J. Bone Miner. Res. 2014 Dec;29(12):2618-35
Mukai T et al
2014/01/01
-
備考:
Application: Neutralization, Sample Type: recombinant protein -
参照: